ストックスクリーナーアプリを入手
10.48
4.28%
0.43
前日終値:
$10.05
開ける：
$10.02
24時間の取引高:
460.44K
Relative Volume:
0.63
時価総額：
$564.14M
収益：
$217.25M
当期純損益:
$-50.92M
株価収益率:
-10.48
EPS:
-1
ネットキャッシュフロー:
$-100.85M
1週間 パフォーマンス:
+5.54%
1か月 パフォーマンス:
+2.59%
6か月 パフォーマンス:
+53.67%
1年 パフォーマンス:
-27.42%
1日の値動き範囲:
$9.90
$10.69
1週間の範囲:
$9.75
$10.69
52週間の値動き範囲:
$4.32
$17.66
Prothena Corporation Plc Stock (PRTA) Company Profile
名前
Prothena Corporation Plc
セクター
電話
011-353-1-236-2500
住所
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
PRTA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
10.48 | 540.99M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-28 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2025-05-27 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | ダウングレード | Jefferies | Buy → Hold |
| 2025-05-27 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-12-20 | 開始されました | Chardan Capital Markets | Buy |
| 2024-01-30 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2023-04-24 | 開始されました | SVB Securities | Outperform |
| 2023-01-27 | 開始されました | Piper Sandler | Overweight |
| 2022-11-04 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-11-19 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-06-18 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-06-08 | 繰り返されました | Oppenheimer | Outperform |
| 2021-05-26 | 開始されました | Citigroup | Buy |
| 2021-02-26 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | アップグレード | Jefferies | Hold → Buy |
| 2021-02-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-12-07 | 開始されました | H.C. Wainwright | Buy |
| 2020-07-09 | アップグレード | Oppenheimer | Perform → Outperform |
| 2019-11-19 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-05-21 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2018-04-23 | ダウングレード | Jefferies | Buy → Hold |
| 2018-04-05 | 繰り返されました | Barclays | Overweight |
| 2017-11-20 | ダウングレード | Wedbush | Outperform → Neutral |
| 2017-09-29 | 繰り返されました | BTIG Research | Buy |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-11 | 開始されました | Jefferies | Buy |
| 2017-04-12 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-04-12 | 開始されました | Piper Jaffray | Overweight |
| 2017-03-02 | 開始されました | Instinet | Buy |
| 2016-12-21 | 開始されました | SunTrust | Buy |
| 2016-11-03 | 開始されました | Deutsche Bank | Buy |
| 2016-08-04 | 繰り返されました | Barclays | Overweight |
| 2016-05-13 | 開始されました | Barclays | Overweight |
| 2016-02-19 | 繰り返されました | Wedbush | Outperform |
| 2016-01-21 | 開始されました | Credit Suisse | Outperform |
すべてを表示
Prothena Corporation Plc (PRTA) 最新ニュース
Prothena (NASDAQ:PRTA) Upgraded at Chardan Capital - Defense World
How Prothena Corporation plc stock performs during Fed tightening cyclesJuly 2025 Reactions & Low Risk Entry Point Guides - newser.com
Prothena Announces Poster Presentation on its TDP-43 CYTOPE® Program at Neuroscience 2025 - BioSpace
Will Prothena Corporation plc stock see PE expansionQuarterly Growth Report & Free Reliable Trade Execution Plans - newser.com
Prothena Shareholders Approve Capital Reduction Proposal - TipRanks
Prothena presents TDP-43 CYTOPE data showing promise for ALS treatment - Investing.com Australia
Prothena (PRTA) Highlights Breakthrough in Drug Delivery at Neur - GuruFocus
Prothena announces poster presentation on its TDP-43 Cytope® program at neuroscience 2025 - MarketScreener
Prothena Announces Poster Presentation On Its TDP-43 Cytope® Program At Neuroscience 2025 - TradingView
What’s the recovery path for long term holders of Prothena Corporation plcPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com
Will Prothena Corporation plc stock see insider buyingWeekly Trend Summary & Community Shared Stock Ideas - newser.com
Understanding Momentum Shifts in (PRTA) - news.stocktradersdaily.com
Will Prothena Corporation plc stock maintain momentum in 2025 - newser.com
What analysts say about Prothena Corporation plc stockStock Price Targets & Download Our Free Trading Blueprint - earlytimes.in
Market reaction to Prothena Corporation plc’s recent newsWeekly Market Summary & Fast Entry High Yield Tips - newser.com
What MACD and RSI say about Prothena Corporation plcTrade Performance Summary & Community Verified Watchlist Alerts - newser.com
What drives Prothena Corporation plc stock pricePrice Action Analysis & Low Risk Investment Plans - earlytimes.in
Can Asarfi Hospital Limited Reach New Highs in YEAR Resistance Levels ReviewedInsider Trading Activity & Test Our Stock Screener — Free Forever - earlytimes.in
Should you hold or exit Prothena Corporation plc nowJuly 2025 Pullbacks & Capital Protection Trading Alerts - newser.com
Will Prothena Corporation plc stock reach all time highs in 2025Weekly Trend Summary & AI Powered Market Trend Analysis - newser.com
Should you wait for a breakout in Prothena Corporation plc2025 Momentum Check & Free Community Supported Trade Ideas - newser.com
How Prothena Corporation plc stock trades before earningsRisk Management & Smart Swing Trading Techniques - newser.com
1,018,177 Shares in Prothena Corporation plc $PRTA Bought by Acadian Asset Management LLC - Defense World
Prothena Corporation Plc (PRTA) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):